can tirzepatide cause heart palpitations New-Onset Atrial Fibrillation Potentially Associated With Tirzepatide: A Case Report Can Weight Loss Injections Cause
Description
Clinical studies reveal this phenomenon, known as telogen effluvium , occurs more frequently in those using GLP-1 medications similar to semaglutide
Patients with high cardiovascular risk may benefit most from weight loss interventions, but they also require optimisation of all modifiable risk factors, including cholesterol management with statins where indicated
They can provide personalized advice and support
503B facilities are also crucial because they strengthen the drug supply chain in the United States
